LONDON--(BUSINESS WIRE)--A well-known market intelligence company, Infiniti Research, has announced the completion of its latest article on pharmaceutical market research: a linchpin for success in ...

New treatments, advanced medical devices, and innovations in everything from human health to animal health are driving growth in the pharmaceutical and biotechnology industries. The biotech and pharma ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

As 2026 approaches, the clinical research and development landscape is evolving beyond traditional scientific innovation with ...

Pharma’s return on investment (ROI) for research and development (R&D) is seeing a comeback after a record low in 2022, according to a recent report out of Deloitte. ROI on pharma R&D jumped to 4.1% ...

insights from industrySree VadlamudiVice President, Head of Business Development EU, RoWIktos As part of our SLAS Europe 2022 coverage, we speak to Dr. Sree Vadlamudi, Vice President BD at Iktos, ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

I examine the applicability of relative R&D spending as a potential leading indicator of shareholder returns. In addition, the correlation of R&D spending with stock volatility and sales growth is ...

From generics dominance to innovation leadership, India’s pharmaceutical sector is scaling rapidly through advanced ...

Cloudbreak Pharma, Inc. ( ($HK:2592) ) has shared an announcement. Cloudbreak Pharma Inc. announced that its subsidiary, Cloudbreak Therapeutics ...